Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: Variation in polypharmacy and antipsychotic use

Pont, LG; Raban, MZ; Jorgensen, ML; Georgiou, A; Westbrook, JI

Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: Variation in polypharmacy and antipsychotic use

Pont, LG

Raban, MZ Jorgensen, ML Georgiou, A Westbrook, JI

Permalink

Publication Type:: Journal Article
Citation:: International Journal for Quality in Health Care, 2018, 30 (10), pp. 810 - 816
Issue Date:: 2018-12-01

Closed Access

	Filename	Description	Size
	mzy098.pdf	Published Version	490.1 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Pont, LG https://orcid.org/0000-0002-8545-716X	en_US
dc.contributor.author	Raban, MZ	en_US
dc.contributor.author	Jorgensen, ML	en_US
dc.contributor.author	Georgiou, A	en_US
dc.contributor.author	Westbrook, JI	en_US
dc.date.available	2018-05-22	en_US
dc.date.issued	2018-12-01	en_US
dc.identifier.citation	International Journal for Quality in Health Care, 2018, 30 (10), pp. 810 - 816	en_US
dc.identifier.issn	1353-4505	en_US
dc.identifier.uri	http://hdl.handle.net/10453/130693
dc.description.abstract	© The Author(s) 2018. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. Objective: The aim of this study was to use routinely collected electronic medicines administration (eMAR) data in residential aged care (RAC) to investigate the quality use of medicines. Design: A cross-sectional analysis of eMAR data. Setting: 71 RAC facilities in New South Wales and the Australian Capital Territory, Australia. Participants: Permanent residents living in a participating facility on 1 October 2015. Intervention: None. Main Outcome Measures: Variation in polypharmacy (?5 medications), hyper-polypharmacy (?10 medications) and antipsychotic use across facilities was examined using funnel plot analysis. Results: The study dataset included 4775 long-term residents. The mean resident age was 85.3 years and 70.6% of residents were female. The median facility size was 60 residents and 74.3% were in metropolitan locations. 84.3% of residents had polypharmacy, 41.2% hyper-polypharmacy and 21.0% were using an antipsychotic. The extent of polypharmacy (69.75-100% of residents), hyper-polypharmacy (38.81-76.19%) and use of antipsychotic medicines (0-75.6%) varied considerably across the 71 facilities. Conclusions: Using eMAR data we found substantial variation in polypharmacy, hyperpolypharmacy and antipsychotic medicine use across 71 RAC facilities. Further investigation into the policies and practices of facilities performing above or below expected levels is warranted to understand variation and drive quality improvement.	en_US
dc.relation.ispartof	International Journal for Quality in Health Care	en_US
dc.relation.isbasedon	10.1093/intqhc/mzy098	en_US
dc.subject.classification	Health Policy & Services	en_US
dc.subject.mesh	Humans	en_US
dc.subject.mesh	Antipsychotic Agents	en_US
dc.subject.mesh	Polypharmacy	en_US
dc.subject.mesh	Aged	en_US
dc.subject.mesh	Aged, 80 and over	en_US
dc.subject.mesh	Homes for the Aged	en_US
dc.subject.mesh	Australian Capital Territory	en_US
dc.subject.mesh	New South Wales	en_US
dc.subject.mesh	Female	en_US
dc.subject.mesh	Male	en_US
dc.subject.mesh	Electronic Health Records	en_US
dc.title	Leveraging new information technology to monitor medicine use in 71 residential aged care facilities: Variation in polypharmacy and antipsychotic use	en_US
dc.type	Journal Article
utslib.citation.volume	10	en_US
utslib.citation.volume	30	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
utslib.for	11 Medical and Health Sciences	en_US
utslib.for	17 Psychology and Cognitive Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.issue	10	en_US
pubs.publication-status	Published	en_US
pubs.volume	30	en_US

Abstract:

© The Author(s) 2018. Published by Oxford University Press in association with the International Society for Quality in Health Care. All rights reserved. Objective: The aim of this study was to use routinely collected electronic medicines administration (eMAR) data in residential aged care (RAC) to investigate the quality use of medicines. Design: A cross-sectional analysis of eMAR data. Setting: 71 RAC facilities in New South Wales and the Australian Capital Territory, Australia. Participants: Permanent residents living in a participating facility on 1 October 2015. Intervention: None. Main Outcome Measures: Variation in polypharmacy (?5 medications), hyper-polypharmacy (?10 medications) and antipsychotic use across facilities was examined using funnel plot analysis. Results: The study dataset included 4775 long-term residents. The mean resident age was 85.3 years and 70.6% of residents were female. The median facility size was 60 residents and 74.3% were in metropolitan locations. 84.3% of residents had polypharmacy, 41.2% hyper-polypharmacy and 21.0% were using an antipsychotic. The extent of polypharmacy (69.75-100% of residents), hyper-polypharmacy (38.81-76.19%) and use of antipsychotic medicines (0-75.6%) varied considerably across the 71 facilities. Conclusions: Using eMAR data we found substantial variation in polypharmacy, hyperpolypharmacy and antipsychotic medicine use across 71 RAC facilities. Further investigation into the policies and practices of facilities performing above or below expected levels is warranted to understand variation and drive quality improvement.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/130693